JP MORGAN/CALL/BOSTON SCIENTIFIC/90/0.1/16.01.26 | Market Closed - Börse Stuttgart 10:15:37 28/06/2024 BST | ||
| 1.06 EUR | -0.93% |
|
| Current month | +3.92% | ||
| 1 month | -2.75% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 1.06 | -0.93% |
| 27/06/24 | 1.07 | +1.90% |
| 25/06/24 | 1.05 | -4.55% |
| 24/06/24 | 1.1 | +2.80% |
| 21/06/24 | 1.07 | -0.93% |
Delayed Quote Börse Stuttgart
Last update June 28, 2024 at 10:15 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK7K5R |
| ISIN | DE000JK7K5R8 |
| Date issued | 11/04/2024 |
| Strike | 90 $ |
| Maturity | 16/01/2026 (566 Days) |
| Parity | 10 : 1 |
| Emission price | 0.33 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.16 € |
|---|---|
| Lowest since issue | 0.68 € |
| Spread | 0.1 € |
| Spread % | 8.70% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
77.01
USD
Average target price
82.35
USD
Spread / Average Target
+6.94%
- Stock Market
- Warrants
- Warrant
